Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
Patient Reported Outcome Measures in cancer care: a hybrid effectiveness-Implementation trial to optimise Symptom control and health service Experience (PROMISE)-protocol for a randomised controlled trial of electronic self-reporting of symptoms versus usual care during and following treatment in patients with cancer.
Webb PM, Brown A, Brown B, Collins LG, Crawford Williams F, Doupain K, Eastgate M, Fennelly V, Girgis A, Hartel G, Ladwa R, Martin K, Mason R, McGuire P, Miller E, O'Brien S, Packer R, Pinkham MB, Sabesan S, Sanmugarajah J, Slapp G, Tapsall D, White J, Wishart LR, Wyld D, Chan RJ. Webb PM, et al. Among authors: eastgate m. BMJ Open. 2024 Nov 19;14(11):e090836. doi: 10.1136/bmjopen-2024-090836. BMJ Open. 2024. PMID: 39566946 Free PMC article.
Stereocontrolled access to thioisosteres of nucleoside di- and triphosphates.
Zhang HJ, Ociepa M, Nassir M, Zheng B, Lewicki SA, Salmaso V, Baburi H, Nagel J, Mirza S, Bueschbell B, Al-Hroub H, Perzanowska O, Lin Z, Schmidt MA, Eastgate MD, Jacobson KA, Müller CE, Kowalska J, Jemielity J, Baran PS. Zhang HJ, et al. Among authors: eastgate md. Nat Chem. 2024 Feb;16(2):249-258. doi: 10.1038/s41557-023-01347-2. Epub 2023 Oct 19. Nat Chem. 2024. PMID: 37857844
Stereocontrolled Radical Thiophosphorylation.
Nassir M, Ociepa M, Zhang HJ, Grant LN, Simmons BJ, Oderinde MS, Kawamata Y, Cauley AN, Schmidt MA, Eastgate MD, Baran PS. Nassir M, et al. Among authors: eastgate md. J Am Chem Soc. 2023 Jul 19;145(28):15088-15093. doi: 10.1021/jacs.3c05655. Epub 2023 Jul 3. J Am Chem Soc. 2023. PMID: 37399078
In Support of Early-Career Researchers.
Bandichhor R, Borovik AS, Bettencourt-Dias A, Eastgate MD, Radu NS, Shi F, McElwee-White L. Bandichhor R, et al. Among authors: eastgate md. J Org Chem. 2023 Feb 17;88(4):1923-1927. doi: 10.1021/acs.joc.3c00130. Epub 2023 Feb 2. J Org Chem. 2023. PMID: 36727963 No abstract available.
In Support of Early-Career Researchers.
Bandichhor R, Borovik AS, Bettencourt-Dias A, Eastgate MD, Radu NS, Shi F, McElwee-White L. Bandichhor R, et al. Among authors: eastgate md. Org Lett. 2023 Feb 10;25(5):715-719. doi: 10.1021/acs.orglett.3c00187. Epub 2023 Feb 2. Org Lett. 2023. PMID: 36727953 No abstract available.
In Support of Early-Career Researchers.
Bandichhor R, Borovik AS, Bettencourt-Dias A, Eastgate MD, Radu NS, Shi F, McElwee-White L. Bandichhor R, et al. Among authors: eastgate md. Inorg Chem. 2023 Feb 13;62(6):2489-2493. doi: 10.1021/acs.inorgchem.3c00207. Epub 2023 Feb 2. Inorg Chem. 2023. PMID: 36727951 No abstract available.
86 results